These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 31585731)

  • 21. Inhibition of ultraviolet B--induced c-fos gene expression and p38 mitogen-activated protein kinase activation by (-)-epigallocatechin gallate in a human keratinocyte cell line.
    Chen W; Dong Z; Valcic S; Timmermann BN; Bowden GT
    Mol Carcinog; 1999 Feb; 24(2):79-84. PubMed ID: 10078934
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epigallocatechin-3 gallate induces growth inhibition and apoptosis in human breast cancer cells through survivin suppression.
    Tang Y; Zhao DY; Elliott S; Zhao W; Curiel TJ; Beckman BS; Burow ME
    Int J Oncol; 2007 Oct; 31(4):705-11. PubMed ID: 17786300
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The role of peroxiredoxin V in (-)-epigallocatechin 3-gallate-induced multiple myeloma cell death.
    Ren L; Yang HY; Choi HI; Chung KJ; Yang U; Lee IK; Kim HJ; Lee DS; Park BJ; Lee TH
    Oncol Res; 2011; 19(8-9):391-8. PubMed ID: 22329198
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Epigallocatechin-3-gallate-induced stress signals in HT-29 human colon adenocarcinoma cells.
    Chen C; Shen G; Hebbar V; Hu R; Owuor ED; Kong AN
    Carcinogenesis; 2003 Aug; 24(8):1369-78. PubMed ID: 12819184
    [TBL] [Abstract][Full Text] [Related]  

  • 25. PDE3 inhibitor and EGCG combination treatment suppress cancer stem cell properties in pancreatic ductal adenocarcinoma.
    Kumazoe M; Takai M; Hiroi S; Takeuchi C; Yamanouchi M; Nojiri T; Onda H; Bae J; Huang Y; Takamatsu K; Yamashita S; Yamada S; Kangawa K; Takahashi T; Tanaka H; Tachibana H
    Sci Rep; 2017 May; 7(1):1917. PubMed ID: 28507327
    [TBL] [Abstract][Full Text] [Related]  

  • 26. (-)-Epigallocatechin-3-gallate promotes pro-matrix metalloproteinase-7 production via activation of the JNK1/2 pathway in HT-29 human colorectal cancer cells.
    Kim M; Murakami A; Kawabata K; Ohigashi H
    Carcinogenesis; 2005 Sep; 26(9):1553-62. PubMed ID: 15860507
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Epigallocatechin-3-gallate inhibits cell cycle and induces apoptosis in pancreatic cancer.
    Shankar S; Suthakar G; Srivastava RK
    Front Biosci; 2007 Sep; 12():5039-51. PubMed ID: 17569628
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Association of suppression of extracellular signal-regulated kinase phosphorylation by epigallocatechin gallate with the reduction of matrix metalloproteinase activities in human fibrosarcoma HT1080 cells.
    Maeda-Yamamoto M; Suzuki N; Sawai Y; Miyase T; Sano M; Hashimoto-Ohta A; Isemura M
    J Agric Food Chem; 2003 Mar; 51(7):1858-63. PubMed ID: 12643642
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Indoleamine 2,3-dioxygenase, an immunomodulatory protein, is suppressed by (-)-epigallocatechin-3-gallate via blocking of gamma-interferon-induced JAK-PKC-delta-STAT1 signaling in human oral cancer cells.
    Cheng CW; Shieh PC; Lin YC; Chen YJ; Lin YH; Kuo DH; Liu JY; Kao JY; Kao MC; Way TD
    J Agric Food Chem; 2010 Jan; 58(2):887-94. PubMed ID: 19928918
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Green tea component, catechin, induces apoptosis of human malignant B cells via production of reactive oxygen species.
    Nakazato T; Ito K; Ikeda Y; Kizaki M
    Clin Cancer Res; 2005 Aug; 11(16):6040-9. PubMed ID: 16115949
    [TBL] [Abstract][Full Text] [Related]  

  • 31. (-)-Epigallocatechin gallate induces Fas/CD95-mediated apoptosis through inhibiting constitutive and IL-6-induced JAK/STAT3 signaling in head and neck squamous cell carcinoma cells.
    Lin HY; Hou SC; Chen SC; Kao MC; Yu CC; Funayama S; Ho CT; Way TD
    J Agric Food Chem; 2012 Mar; 60(10):2480-9. PubMed ID: 22313388
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Phosphodiesterase 5 Inhibitor Potentiates Epigallocatechin 3-O-Gallate-Induced Apoptotic Cell Death via Activation of the cGMP Signaling Pathway in Caco-2 Cells.
    Bae J; Lee K; Park JS; Jung J; Tachibana H; Fujimura Y; Kumazoe M; Lim JS; Cho YC; Lee SJ; Park SJ
    Curr Issues Mol Biol; 2022 Dec; 44(12):6247-6256. PubMed ID: 36547087
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Epigallocatechin-3-gallate enhances ischemia/reperfusion-induced apoptosis in human umbilical vein endothelial cells via AKT and MAPK pathways.
    Zhang T; Yang D; Fan Y; Xie P; Li H
    Apoptosis; 2009 Oct; 14(10):1245-54. PubMed ID: 19669889
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigallocatechin-3-gallate (EGCG) inhibits PC-3 prostate cancer cell proliferation via MEK-independent ERK1/2 activation.
    Albrecht DS; Clubbs EA; Ferruzzi M; Bomser JA
    Chem Biol Interact; 2008 Jan; 171(1):89-95. PubMed ID: 17931610
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tea polyphenol (-)-epigallocatechin 3-gallate suppresses heregulin-beta1-induced fatty acid synthase expression in human breast cancer cells by inhibiting phosphatidylinositol 3-kinase/Akt and mitogen-activated protein kinase cascade signaling.
    Pan MH; Lin CC; Lin JK; Chen WJ
    J Agric Food Chem; 2007 Jun; 55(13):5030-7. PubMed ID: 17539658
    [TBL] [Abstract][Full Text] [Related]  

  • 37. EGCG-targeted p57/KIP2 reduces tumorigenicity of oral carcinoma cells: role of c-Jun N-terminal kinase.
    Yamamoto T; Digumarthi H; Aranbayeva Z; Wataha J; Lewis J; Messer R; Qin H; Dickinson D; Osaki T; Schuster GS; Hsu S
    Toxicol Appl Pharmacol; 2007 Nov; 224(3):318-25. PubMed ID: 17196232
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Epigallocatechin gallate inhibits the proliferation and induces apoptosis of multiple myeloma cells via inactivating EZH2.
    Zhou CG; Hui LM; Luo JM
    Eur Rev Med Pharmacol Sci; 2018 Apr; 22(7):2093-2098. PubMed ID: 29687868
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Potentiation of (-)-epigallocatechin-3-gallate-induced apoptosis by bortezomib in multiple myeloma cells.
    Wang Q; Li J; Gu J; Huang B; Zhao Y; Zheng D; Ding Y; Zeng L
    Acta Biochim Biophys Sin (Shanghai); 2009 Dec; 41(12):1018-26. PubMed ID: 20011976
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Epigallocatechin gallate sensitizes cisplatin-resistant oral cancer CAR cell apoptosis and autophagy through stimulating AKT/STAT3 pathway and suppressing multidrug resistance 1 signaling.
    Yuan CH; Horng CT; Lee CF; Chiang NN; Tsai FJ; Lu CC; Chiang JH; Hsu YM; Yang JS; Chen FA
    Environ Toxicol; 2017 Mar; 32(3):845-855. PubMed ID: 27200496
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.